Leadership
Founder, Chairman of the Board, CEO
Larry is a serial entrepreneur in the healthcare and telecommunications. He is the co-inventor of an innovative technique in neural networks for object orientation detection.
Chief Medical Officer, Board Member
Trained at Yale School of Medicine and Cornell-New York Hospital, Charisse had a successful neurology private practice for 25 years, was on the faculty of Yale School of Medicine, worked with a Contract Research Organization monitoring pharmaceutical trials, and created a migraine service at a Telehealth company.
Medical Advisor, Board Member
Timothy Vartanian, MD, PhD, is a leading authority on neural regeneration and is the Director of the Judith Jaffe MS Center at New York-Presbyterian Hospital / Weill Cornell Medical Center.
Chief Commercial Officer
Alan is a mission-driven growth serial entrepreneur with an ‘up through the ranks’ experience in the healthcare industry focused on the achievement of systematically improved outcomes and reduced costs across the healthcare continuum.
Computational Neuroscience Advisor, Board Member
Dave is a physio-therapist with a PhD on neural control and reaching. At Harvard and MIT, David’s positions focused on computational neuroscience. Previously, at NYU, he concentrated on motor control and brain machine interface development research.
Advisors
Dr. Sharon Stoll
Yale School of Medicine
A board-certified neurologist and assistant professor at Yale School of Medicine, Dr. Stoll has received numerous awards, including Top Neurologist 2021, Rodney Bell teaching award and is a national multiple sclerosis society grant recipient.
Dr. Huned Patwa
Yale School of Medicine
Dr. Patwa is a Professor of Neurology at the Yale School of Medicine, and co-director of the Muscular Dystrophy Association Clinic. His research is focused on diseases of the peripheral nervous system including amyotrophic lateral sclerosis (ALS) myasthenia gravis and peripheral neuropathy.
Mark Herceg, Ph.D
Clinical and Sports Neuropsychologist. Founder, Head Strong Diagnostics, LLC
Dr. Herceg has spent over 20 years evaluating and treating individuals with various neurological changes, illnesses or brain injuries. A graduate of Hofstra University’s Zucker School of Medicine, he served as the Commissioner of Westchester County Department of Mental Health and is the past Chair of the BIA-New York State Concussion Task Force.
KOLs
Riley Bove, MD MSc
Associate Professor | UCSF Weill Institute for Neurosciences|
Principal Investigator at the Bove Lab at University of California, San Francisco; who’s mission is to develop new tools to promote healing and repair in people with MS. Dr Bove obtained her MD from Harvard Medical School, completed her residency at Mass General/Brigham and Women’s Hospital Neurology program, and her Masters Degree through Harvard Medical School’s Clinical Investigator Training Program.
Mitzi Williams, MD
Founder, CEO of Joi Life Wellness Group Multiple Sclerosis Center
Dr. Mitzi Joi Williams is a Board-Certified Neurologist, Fellowship Trained Multiple Sclerosis Sprecialist. Author, International Speaker and Researcher who is passionate about educating and empowering people affected by MS.
Darin T. Okuda, MD, FAAN, FANA
Department of Neurology | UT Southwestern Medical Center at Dallas
Neurologist Darin T. Okuda, MD is a nationally and internationally recognized clinician-scientist and technology expert specializing in the diagnosis and treatment of multiple sclerosis (MS) and other demyelinating disorders of the central nervous system. He serves as Director of the Multiple Sclerosis and Neuroimmunology Imaging Program, Director of Neuroinnovation, and Deputy Director of the Multiple Sclerosis Program and Clinical Center for Multiple Sclerosis at UT Southwestern.
Aaron Boster, MD
President, Boster Center for Multiple Sclerosis, Columbus, OH
Dr. Aaron Boster, is a board-certified Neurologist specializing in Multiple Sclerosis and related CNS inflammatory disorders. He graduated from University Of Cincinnati College Of Medicine, and completed an internship in Internal Medicine and Residency in Neurology at the University of Michigan. Since then he has been intimately involved in the care of people impacted by Multiple Sclerosis.
Publications
BeCare has run two pilot studies, at Weill Cornell and Yale School of Medicine, comparing the remote neurologic assessment captured by and the Artificial Intelligence interpretation created using the BeCare MS Link data with the in-person neurologic assessment by clinicians. There was a close correlation between the functional assessment and disability scores based on BeCare MS Link’s gamified activity and the EDSS score calculated in the MS centers.
A review of available MS apps failed to show any other apps that collect quantified data and have AI interpretation of functional systems and disability scores similar to the BeCare MS Link.
Rubin, L., M Kruse-Hoyer, C Litchman, S Stoll, D Putrino, S Shetty, C Engel, M Marcille, S Gauthier, J Perumal, N Nealon, U Kaunzer, T Vartanian. “Patient Centered Outcomes Analysis for Multiple Sclerosis Using a Mobile Application” Fourth Annual American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Dallas, TX. Feb 2019.
Stoll, S., T Litchman, S Wesley, C Litchman, “Multiple sclerosis apps: The dawn of a new era: A comprehensive review” 71st Annual American Academy of Neurology (AAN), Philadelphia, PA . May 2019.
Litchman, C., T Vartanian, L Rubin, N Rubin, S Stoll. Automated EDSS scoring using a mobile App & Machine Learning. 72st Annual American Academy of Neurology (AAN), Toronto, Canada, 2020.
Stoll, S. N Rubin, L Rubin, T Litchman, J Keaney,T Vartanian, , C Litchman. Machine Learning Evaluation of MS patients during the time of COVID. 73rd Annual American Academy of Neurology (AAN), 2021.
Liam Johnson, Adam Fry, Behdad Dehbandi, Lawrence Rubin , Michael Halem, Alexandre Barachant , Anna H. Smeragliuolo, David Putrino An automated, electronic assessment tool can accurately classify older adult postural stability , Journal of Biomechanics, BM 9228 No. of Pages 5, Model 5G 6 June 2019
ONGOING STUDIES
Sensation, Motion, and Quality of Life on Natalizumab and off Natalizumab – a Biogen sponsored study being conducted at Mount Sinai Medical Center. The goal of this study is to explore the basis of the patient-reported “Feel Good Effect” of Tysabri using the BeCare MS Link app.
If you would like to participate, please contact LAURA TABACOF
(212) 824-8369; [email protected] or contact [email protected].